Prognosis in small vessel vasculitis

Abstract

ANCA-associated vasculitis (AAV) is a systemic autoimmune

disease which is associated with increased risk of mortality and morbidity.

The outcomes of patients with AAV have improved substantially as a

consequence of earlier detection of the disease and more sophisticated therapy regimens. Despite these advances, the disease influences the lives of patients substantially. Therefore, this thesis focused on prognosis and outcomes with the aim to further improve the outcomes of patients with AAV.